Positive interactions with healthcare workers improve HIV care retention in Malawi and Zambia
Studies confirm non-inferiority of doravirine / islatravir to standard HIV treatment
Large fall in severe illnesses over two decades in Spain, while co-morbidities stay stable
Event-driven PrEP for women may work, modelling study predicts
PEPFAR study shows the deadly impact of stopping children’s HIV treatment
Lenacapavir plus broadly neutralising antibodies could be twice-yearly HIV treatment
Half the men in an HIV cure study stayed off treatment for nearly a year after a two-antibody shot
Radical changes in US policy threaten two decades’ progress in HIV
Two more people with HIV may be cured after stem cell transplants
